单纯糖皮质激素诱导的股骨转子下非典型股骨骨折一例
本文报告一例58岁男性股骨转子下非典型股骨骨折(AFF),其唯一已知风险因素为长期使用糖皮质激素,无双膦酸盐用药史及其他骨代谢疾病。骨折固定后更换糖皮质激素为替代药物,术后14个月骨折完全愈合。提示糖皮质激素单独即可诱导AFF,长期使用者需定期评估并纠正风险因素。
要点
- 长期糖皮质激素治疗可能是AFF的独立风险因素,即使无双膦酸盐暴露史。
- 接受长期糖皮质激素治疗者应定期评估AFF风险并纠正可调控因素。
- 纠正风险因素(如更换糖皮质激素)可能促进AFF术后骨愈合。
核心结论
- 糖皮质激素单独使用即可诱导股骨转子下非典型股骨骨折(AFF)。
- 长期糖皮质激素治疗患者需定期评估AFF风险并纠正风险因素。
- 纠正风险因素可能加速AFF骨折愈合。
研究设计与样本
- 个案报道,报告一例58岁男性股骨转子下AFF患者的诊疗经过。
主要发现
- 患者无骨代谢疾病史及AFF已知风险因素,仅长期使用糖皮质激素。
- 骨折固定后糖皮质激素被替换为替代药物,术后14个月骨折完全愈合。
临床怎么用
- 对长期使用糖皮质激素的患者应警惕AFF可能,定期进行风险评估。
- 发现AFF后应考虑纠正可调控的风险因素(如调整糖皮质激素方案)。
局限性
- 单一个案报道,证据级别有限,不能确立因果关系或推广至所有长期糖皮质激素使用者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
An AFF is a form of stress fracture induced by excessive physiologic repetitive stress over the bone remodeling capacity. Although glucocorticoid administration is a known risk factor for AFF, no case of AFF with glucocorticoid administration as the only risk factor has been previously reported. In this report, we aimed to highlight the risk of AFF associated with long-term administration of glucocorticoids, and the importance of surveillance and correction of risk factors in patients undergoing long-term glucocorticoid therapy. A 58-year-old male patient was diagnosed with subtrochanteric AFF. He had no medical history of any condition that might disrupt bone metabolism and no known risk factors for AFF, except for long-term administration of glucocorticoid. After fixation of the fracture, the glucocorticoid was replaced with an alternative medication. Although AFF is notorious for delayed union or nonunion, complete union of the fracture was obtained at 14 months postoperatively. This case brought to our attention the possibility that glucocorticoids alone may be responsible for inducing AFF and highlighted the importance of regular assessments in case of necessity of glucocorticoid administration. Additionally, correction of risk factors might expedite the union of AFF.
引用
- Kim JT, Cha YH, Jeong S, et al. Subtrochanteric atypical femoral fracture induced solely by glucocorticoid without bisphosphonate treatment: a case report. Osteoporos Int. 2021. PMID: 33893546. doi:10.1007/s00198-021-05971-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。